One-month alcohol abstinence national campaigns: a scoping review of the harm reduction benefits.
Abstinence campaigns
Alcohol abstinence
Dry January
One-month abstinence
Journal
Harm reduction journal
ISSN: 1477-7517
Titre abrégé: Harm Reduct J
Pays: England
ID NLM: 101153624
Informations de publication
Date de publication:
04 03 2022
04 03 2022
Historique:
received:
29
09
2021
accepted:
17
02
2022
entrez:
5
3
2022
pubmed:
6
3
2022
medline:
15
3
2022
Statut:
epublish
Résumé
Over the last decade, one-month alcohol abstinence campaigns (OMACs) have been implemented within the general population in an increasing number of countries. We identified the published studies reporting data on OMACs to explore the following aspects: profile of participants, rates and factors associated with the completion of the abstinence challenge, and outcomes and harm reduction benefits in participating in the challenges. We screened 322 records, including those found in the grey literature, and reviewed 6 studies and 7 Dry July Annual Reports. Compared to non-participating alcohol users, participants were more likely to be female, have a higher income, and a higher level of education. They were heavier drinkers and were more concerned by the consequences of alcohol on health and by their health in general. Participants who achieved the one-month abstinence challenge were lower drinkers and more likely to have registered on the campaign-related Internet communities. Both successful and unsuccessful participants frequently reported health benefits, including sleep improvement and weight loss. Successful participants were more likely to durably change their alcohol drinking habits. Overall, OMACs provide short- or mid-term harm reduction benefits for both successful and unsuccessful participants. Findings were limited by the paucity of studies, their observational nature, and heterogeneity in the features of the different national campaigns, which would probably gain in enhanced internationalization.
Identifiants
pubmed: 35246148
doi: 10.1186/s12954-022-00603-x
pii: 10.1186/s12954-022-00603-x
pmc: PMC8895623
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
24Informations de copyright
© 2022. The Author(s).
Références
Addict Behav. 2021 Mar;114:106745
pubmed: 33310691
Br J Gen Pract. 2016 Jan;66(642):32
pubmed: 26719465
Drug Alcohol Depend. 2021 Oct 1;227:108938
pubmed: 34392050
N Engl J Med. 2008 Jun 5;358(23):2468-81
pubmed: 18525043
Alcohol Alcohol. 2020 Jun 25;55(4):433-438
pubmed: 32391879
Addict Behav. 1996 Nov-Dec;21(6):779-88
pubmed: 8904943
Annu Rev Sociol. 2010 Aug;36:349-370
pubmed: 21909182
Am J Public Health. 2006 Jul;96(7):1181-6
pubmed: 16735622
Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
Z Gesundh Wiss. 2017;25(4):339-349
pubmed: 32215245
Drug Alcohol Depend. 2014 Feb 1;135:52-8
pubmed: 24322004
Alcohol Alcohol. 2018 Jul 1;53(4):435-438
pubmed: 29726886
Health Soc Care Community. 2019 Jul;27(4):863-870
pubmed: 30592341
BMC Public Health. 2019 Dec 16;19(1):1688
pubmed: 31842808
BMJ Open. 2018 May 5;8(5):e020673
pubmed: 29730627
Lancet. 2018 Apr 14;391(10129):1513-1523
pubmed: 29676281
Psychol Health. 2020 Nov;35(11):1293-1305
pubmed: 32216557
Cochrane Database Syst Rev. 2012 Dec 12;12:CD006747
pubmed: 23235633
Lancet. 2010 Nov 6;376(9752):1558-65
pubmed: 21036393
Cochrane Database Syst Rev. 2019 Feb 20;2:CD013272
pubmed: 30784046
Addict Behav. 2002 Nov-Dec;27(6):867-86
pubmed: 12369473
Health Promot Chronic Dis Prev Can. 2016 Apr;36(4):63-75
pubmed: 27077792
J Hepatol. 2013 Jul;59(1):160-8
pubmed: 23511777
Lancet. 2018 Sep 22;392(10152):1015-1035
pubmed: 30146330
Int J Health Serv. 2015;45(4):657-78
pubmed: 25995305
Health Psychol. 2016 Mar;35(3):281-9
pubmed: 26690637
Health Promot J Austr. 2018 Dec;29(3):321-327
pubmed: 30511486
Eur J Public Health. 2017 Oct 1;27(5):929-931
pubmed: 28957493
Lancet Oncol. 2021 Aug;22(8):1071-1080
pubmed: 34270924
Addiction. 2005 Dec;100(12):1763-9
pubmed: 16367976
Br J Cancer. 2015 Feb 3;112(3):580-93
pubmed: 25422909